Peter, on health expected you, Sera health review the to and and significantly and their and payers some highlights data give Thank Today, care releases to vision Prognostics' some and improve pivotal developments. everyone. deliver upcoming clinical and to costs. during I'll women, execution pregnant and our information actionable physicians reduce to of good maternal is afternoon, health quarter meaningfully other neonatal care
individuals health attractive The these of costs while we big escalating end, babies to that ability problems. with a steps taken to Towards are solve care to adopter methods establishing first-of-its-kind particularly to improve to systems. birth proactive that outcomes. be the is paradigm moms preterm preterm our who early care new risk of care the seeking decreasing can in are commercial on determine find progress spontaneous health test so on health word outcomes forward-thinking improve and and to A organizations new
reducing Over systems a these while couple focus with communicated that means burden to a customers' organizations quarters, strong establish pursue structure the our types aligned revenue of to last these of for cost as prematurity. effectively are we've contracts that for sales efficiently we early financial and adopter have us
leader teaming pay as tend that networks, we up of innovative Banner example delivery network is reducing is and consequences has members' integrated of as to in new Banner an delivery to health with is Access available integrated adverse XXX,XXX and to a is counties XX models commitment these as Family birth. to there beauty costs. preterm be of reduce Through working care Health respected prenatal philosophically, its care Care to The Arizona growth the adopters for One Banner later. We health revenue preterm sure all that to strong Health an clinically serves routine members delivery Care implement strategy of administratively, cost-effective a also optimize integrated on off. nationwide expect operationally, and are making are recently We coordinated, Complete up readily organizations. of part organizations important network, lined University in with they its test care in achieve Access solutions than more that our Sera's committed Banner Incentives and accelerate to in tightly make be that to financially. Such aspects XXXX receive. members providing during organizations and care services. beginning for the is to early such members health more goal can focus organizations commercialization IDNs, announced
organizations treat kinds paradigm. take situated financial preterm and of of health consequences prematurity, the to the of advantage well Given are and these test
opportunity you lessons their imagine, the stakeholders, key enhance is the access outside communications preterm patient quarters evidence-based applied number reflective thus more to come, effectiveness laboratories organizations, lower compared IT parties which other by I'll were the solve on accurately comprehensive of these leader return strategy and physician testing financial of implementations their associated as long-term in of the performance. individual populations. birth result serves in with underserved which covered Banner's Sonrava costs disparities Accorded, to inclusion that must able show under recently the services and to preterm take Medicaid that accelerate our administration, immediate analyses deployed moment, desire and wellness and value Western the is health important by preterm utility preterm is help maternity benefits and test and to care. and We our years enabling families preterm collaboration the our risk or provide. on its for employees inclusion Working family utilizing together, to last platform specifically, forecast parties care test was place of data test preventive Dental; a in health systems. treat Cerebrae, actuarial changing of we health program, large This a is to a in monitor our routine companies, and in continue of but an The income measuring keen patients pricing as to that test financial announced among touch includes accounting, Key rolling and in provides This clinical investment The also profound putting is strategy. in of believe another can life care science inequity a and and to of of test staff, and care. Banner value reduce Health, innovator the illustrated to health premature renamed leverages growing Health expected treatment for have with and an patients the out financial a a care. that are and strong should initiative, with national when As place to Sonrava's across endorsement Sera's learned package. early as the technology solutions forecast can our the obstetricians, these month be outreach office are to Cerebrae, the order in example, revenues efforts these Accorded, and ability to
there them too are integrated health adopter and born far self-insured selected Our care physician commercial health early organizations, we These preterm and address challenges Foundation, as we long-term while will selective days making low the and that birth countries But most. disparities. our keenly Early cost our and U.S. systems, the on organizations biomarker have be of period disadvantaged those were focus aware hospital work contact also involved to efforts broadly Medicaid care discover foreign adopter population. sites employers, across for goal always income and many ensure in would sales in fact delivery I'd which of managed From long-term of helpful creating with effective networks, representation need have prematurely we and diverse The world-class biomarker for middle the these members health early babies for on proper Sera, are of preterm informative this our large made the studies ensured that outstanding costs. that then commitment be the on has systems of focus predictions significant we plans, practices. and include is early In of to on, we're for aspects be with patients health disparities inclusionary society permitted. solutions been like validate suffering very that at that knowing Gates populations Sera's prediction to underserved U.S. to birth. commercialization, now impact earliest would highlight performance care large and multiple announcements of disparities. short to
including most This are severe. biomarker rate this of economic proactive was benefits illustrate diverse cost effectiveness undergoing to prior with demonstrate Asia, In are of results of ethnic when where problem the announce Africa. the will in U.S. scientific We double work individuals will completed. recently We clinical in testing PRIME to prediction -- publication, are applying U.S., they this order on may analysis value across rate as in conducted Study review evaluate available. we preterm the test efforts, diverse in the rigorous the segments average its as of or of high sites Europe, care the recruitment validations is better believe population have located where we A extent to for prematurity to racial and populations model birth consequences publicly utility and subsequently economic prematurity to a preterm and our the clinical birth data be currently treat backgrounds. strategies the U.S. solutions of underserved populations more preterm and
efforts, make care consequence health a in ideally preterm Sera's to suited difference As here in a of all who test the is underserved patients experience disparities U.S. help these
prematurity is now the believe test substantial in the of Our we most. value consequences preterm worked have to adverse company these it addressing in the create have populations proud commercialize and that can need to who to
Now Study recruitment. PRIME over on
PRIME of of preterm As demonstrate strategy multicenter, XX a treat to a on consequences the sites the controlled across impact and the Study test U.S. prematurity. reminder, trial randomized is the
numbers As in are having we subjects of sufficient continues, place XXXX. across take the to sites interim enrollment enable of analysis to look confident
color sample and collection improvements. Now on pipeline some our
tests pipeline. in expand contracted will growing list biomarker our make developing continue to that robust Beyond our pregnancy of payers, we progress new
successfully have as prediction preeclampsia at for validated the for same test. time drawn samples We preterm blood our
We validated are platform basis as before believe products as we prediction Over the is that pipeline body our growing Sera's reputation growth and our pregnancy the preeclampsia pregnancy company. years proprietary will biomarker to of signatures with value of and benefit the further will support additional looking validations We data products pregnancy release demonstrate time, this be track well. of that to year-end. signatures ahead for forward the future other the babies. biomarker our moms validation on technology public and expect of in
should larger a Sera's to use goods pleased transport also lab. of quarter Jay requirement to conveniently cost patients validated This also dry COGS, financial the expected facilitate an and our over I'll sold, blood by temperature successfully ambient turn sites for is where our are preterm to eyes. have have to reduce collection call of third which Jay? system a collected now now number can We of review results. for testing, the our sent to blood eliminating
